Genervon Biopharmaceuticals
CA - PasadenaPharmaceutical
Focus: Genervon is a synthetic peptide-focused biotech specializing in neurology, with a pipeline of three Phase 2 programs targeting high-burden CNS diseases. The company operates from Pasadena, California in the competitive neurodegeneration space.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Genervon Biopharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Genervon Biopharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
GM602
StrokeClinical Trials (1)
NCT01221246Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours
Phase 2Help build intelligence for Genervon Biopharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.